Skip to main navigation Back to AbbVie.com Menu |Investors Focused on results, dedicated to innovations AbbVie is a global biopharmaceutical company with focus and capabilities to address some of the world's greatest health challenges. AbbVie discovers, develops, and commercializes advanced therapies that have an impact on people's lives. Today, our passionate AbbVie team has approximately ~48,000 employees working together to help patients around the world. Shareholder contacts | Events | Email alerts Investor resources FAQs and tax information Answers to questions concerning AbbVie stock purchase, dividends, and how to contact AbbVie's transfer agent and Investor Relations. Explore 11/24/21 4:02 PM EST ABBV Common Stock $118.66 Price -0.22 Change Events & presentations Upcoming events and latest webcast View all upcoming and past events. Explore The principal market of AbbVie's common shares is the New York Stock Exchange. Shares are also listed on the Chicago Stock Exchange and traded on various regional and electronic exchanges. Contact Site Map Privacy Policy Terms of Use Copyright © 2021 AbbVie Inc. North Chicago, Illinois, U.S.A Unless otherwise specified, all product names appearing in this internet site are trademarks owned by or licensed to AbbVie Inc., its subsidiaries or affiliates. No use of any AbbVie trademark, trade name, or trade dress in this site may be made without the prior written authorization of AbbVie Inc., except to identify the product or services of the company. This site uses cookies to personalize content, save your preferences, provide social media features, enable personalized advertising and track the site's performance as described in our Privacy Notice. Please review your Cookie Settings to confirm your choices before continuing to browse this site. You can make changes at any time by accessing the Cookie Settings link in the footer of this site. Cookies Settings